BioInvent International AB (BINV) — Strategic Asset Allocation Index
BioInvent International AB (BINV) has a Strategic Asset Allocation Index of 5.2% as of December 2024. Strategic assets (PP&E of Skr46.02 Million plus long-term investments of Skr-) total Skr46.02 Million, measured against net assets of Skr885.82 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
BioInvent International AB Strategic Asset Allocation Index (2000–2024)
This chart shows how BioInvent International AB's Strategic Asset Allocation Index has evolved across 25 annual periods from 2000 to 2024. As of December 2024, the index stands at 5.2%, representing strategic assets of Skr46.02 Million against net assets of Skr885.82 Million SEK. Explore BioInvent International AB operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for BioInvent International AB (2000–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for BioInvent International AB from 2000 to 2024, covering 25 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see BINV stock market capitalisation.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 5.2% | Skr46.02 Million | Skr46.02 Million | Skr- | Skr885.82 Million | ▲ +1.2 pp |
| 2023 | 4.0% | Skr52.66 Million | Skr52.66 Million | Skr- | Skr1.31 Billion | ▲ +0.8 pp |
| 2022 | 3.2% | Skr52.01 Million | Skr52.01 Million | Skr- | Skr1.61 Billion | ▼ -0.4 pp |
| 2021 | 3.6% | Skr49.08 Million | Skr49.08 Million | Skr- | Skr1.37 Billion | ▼ -0.4 pp |
| 2020 | 4.0% | Skr29.60 Million | Skr29.60 Million | Skr- | Skr743.50 Million | ▼ -15.5 pp |
| 2019 | 19.5% | Skr33.01 Million | Skr33.01 Million | Skr- | Skr169.44 Million | ▼ -1.1 pp |
| 2018 | 20.6% | Skr18.03 Million | Skr18.03 Million | Skr- | Skr87.62 Million | ▲ +5.8 pp |
| 2017 | 14.8% | Skr19.25 Million | Skr19.25 Million | Skr- | Skr130.22 Million | ▲ +12.3 pp |
| 2016 | 2.5% | Skr5.65 Million | Skr5.65 Million | Skr- | Skr230.44 Million | ▼ -2.0 pp |
| 2015 | 4.5% | Skr1.32 Million | Skr1.32 Million | Skr- | Skr29.45 Million | ▲ +0.1 pp |
| 2014 | 4.4% | Skr2.30 Million | Skr2.30 Million | Skr- | Skr52.43 Million | ▼ -3.6 pp |
| 2013 | 8.0% | Skr3.93 Million | Skr3.93 Million | Skr- | Skr49.01 Million | ▼ -6.2 pp |
| 2012 | 14.2% | Skr6.78 Million | Skr6.78 Million | Skr- | Skr47.62 Million | ▲ +6.3 pp |
| 2011 | 8.0% | Skr11.01 Million | Skr11.01 Million | Skr- | Skr137.95 Million | ▼ -7.1 pp |
| 2010 | 15.1% | Skr11.20 Million | Skr11.20 Million | Skr- | Skr74.19 Million | ▼ -6.4 pp |
| 2009 | 21.5% | Skr11.97 Million | Skr11.97 Million | Skr- | Skr55.63 Million | ▲ +14.4 pp |
| 2008 | 7.1% | Skr16.43 Million | Skr16.43 Million | Skr- | Skr231.30 Million | ▲ +1.4 pp |
| 2007 | 5.7% | Skr12.28 Million | Skr12.28 Million | Skr- | Skr214.12 Million | ▼ -6.5 pp |
| 2006 | 12.2% | Skr13.44 Million | Skr13.44 Million | Skr- | Skr110.15 Million | ▲ +7.0 pp |
| 2005 | 5.2% | Skr11.39 Million | Skr11.39 Million | Skr- | Skr219.00 Million | ▼ -5.3 pp |
| 2004 | 10.6% | Skr22.44 Million | Skr22.44 Million | Skr- | Skr212.68 Million | ▼ -0.8 pp |
| 2003 | 11.3% | Skr34.55 Million | Skr34.55 Million | Skr- | Skr304.96 Million | ▲ +0.2 pp |
| 2002 | 11.1% | Skr43.82 Million | Skr43.82 Million | Skr- | Skr394.25 Million | ▲ +0.7 pp |
| 2001 | 10.4% | Skr40.51 Million | Skr40.51 Million | Skr- | Skr388.42 Million | ▼ -3.8 pp |
| 2000 | 14.2% | Skr22.74 Million | Skr22.74 Million | Skr- | Skr159.63 Million | — |